Endometrial Carcinoma Clinical Trials

108 clinical trials for Endometrial Carcinoma across international registries, including 24 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma — RECRUITING · PHASE3
• A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer — RECRUITING · NA
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas — RECRUITING · PHASE2
• FOG-001 in Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer — RECRUITING
• A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer — RECRUITING · PHASE1
• Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding — RECRUITING
• Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors — RECRUITING · PHASE1
• Molecular and ctDNA Characterization of High-Risk Endometrial Cancer — RECRUITING
• Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer — RECRUITING · PHASE1
• FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• Screening and Staging of Benign vs Malignant Pelvic Abnormalities — RECRUITING
• GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer — RECRUITING · PHASE1
• An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study — RECRUITING · NA
• Study of GV20-0251 in Participants With Solid Tumor Malignancies — RECRUITING · PHASE1
• ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation — RECRUITING
• Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia — RECRUITING · NA
• A Beta-only IL-2 ImmunoTherapY Study — RECRUITING · PHASE1
• First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer — RECRUITING · PHASE2
• Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer — RECRUITING
• A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies — RECRUITING · PHASE1
• Clinicopathological Analysis of Endometrial Carcinoma in the View of Old and New International Federation of Gynecology and Obestetrics (FIGO) — RECRUITING
• Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer — RECRUITING · PHASE2
• Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma — RECRUITING · PHASE2
• A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations — ACTIVE_NOT_RECRUITING · PHASE1
• Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain — NOT_YET_RECRUITING · PHASE4
• Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) — ACTIVE_NOT_RECRUITING · PHASE2
• Elemene Liposomes in Endometrial Cancer — NOT_YET_RECRUITING · PHASE2
• Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction — ACTIVE_NOT_RECRUITING · PHASE1
• Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial — NOT_YET_RECRUITING · NA
• NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours — TERMINATED · PHASE1
• Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer — ACTIVE_NOT_RECRUITING · NA
• Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO — ACTIVE_NOT_RECRUITING · PHASE3
• Pilot Window of Opportunity Trial (POET) — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Short-course Hypofractionated Online-adaptive Radiotherapy for the Post-operative Treatment of Endometrial Cancer: Tolerability and Feasibility — NOT_YET_RECRUITING · NA
• Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy — NOT_YET_RECRUITING · NA
• A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma — TERMINATED · PHASE2
• Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy — ACTIVE_NOT_RECRUITING · PHASE2
• Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma — COMPLETED · NA
• Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors — ACTIVE_NOT_RECRUITING
• Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) — ACTIVE_NOT_RECRUITING · PHASE1
• Endometrial Carcinoma: Comparison of Surgical Approaches (Laparoscopy vs Laparotomy) — ACTIVE_NOT_RECRUITING
• Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy — ACTIVE_NOT_RECRUITING
• AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer — WITHDRAWN · PHASE1
• Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer — ACTIVE_NOT_RECRUITING
• A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma — TERMINATED · PHASE2
• Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer — ACTIVE_NOT_RECRUITING
• Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer — WITHDRAWN · NA
• IMMUNOTHERAPY EFFICACY TARGETING ENDOMETRIAL CANCER — NOT_YET_RECRUITING · NA

Refine this search